Form 4 for MODD Modular Medical, Inc.
Accepted 2022-02-22 00:00:00 ET · period of report 2022-01-26 · accession 0001019056-22-000224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-22 | 2022-02-14 | MODD | DiPerna Paul | See Remarks, Dir, 10% | M - OptEx | — | +23.4K | 2.54M | +0.9% | — |
| DM | 2022-02-22 | 2022-02-14 | MODD | DiPerna Paul | See Remarks, Dir, 10% | M - OptEx | — | 0 | 0 | New | — |
| D | 2022-02-22 | 2022-01-26 | MODD | DiPerna Paul | See Remarks, Dir, 10% | P - Purchase | — | +11.3K | 11.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-14 | M | A | 23,429 | — | 2,543,585 | D | — | — | (F1) The convertible promissory note (the "Note") was issued to the Paul DiPerna Trust on April 30, 2021, in the principal aggregate amount of $102,663, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $9,788 and an outstanding balance of $112,451. Pursuant to its terms, the Note was automatically converted, on February 14, 2022, into (i) 23,429 shares of common stock of the Issuer and (ii) warrants to purchase 23,429 shares of common stock of the Issuer. |
| 2 | Derivative | Common Stock Purchase Warrant | 2022-02-14 | M | A | 23,429 | — | 23,429 | D | $6.60 · 2022-02-14 to 2027-02-14 | 23,429 Common Stock | (F1) The convertible promissory note (the "Note") was issued to the Paul DiPerna Trust on April 30, 2021, in the principal aggregate amount of $102,663, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $9,788 and an outstanding balance of $112,451. Pursuant to its terms, the Note was automatically converted, on February 14, 2022, into (i) 23,429 shares of common stock of the Issuer and (ii) warrants to purchase 23,429 shares of common stock of the Issuer. |
| 3 | Derivative | Common Stock Purchase Warrant | 2022-01-26 | P | A | 11,294 | — | 11,294 | D | $6.00 · 2022-01-26 to 2027-01-26 | 11,294 Common Stock | (F2) The common stock purchase warrant (the "Warrant") was issued to the Paul DiPerna Trust on April 30, 2021 (the "Issuance Date"). Pursuant to its terms, the Warrant became exercisable on January 26, 2022, the day that is 271 calendar days following the Issuance Date. |
| 4 | Derivative | Convertible Promissory Note | 2022-02-14 | M | D | 23,429 | — | 0 | D | $6.00 · — to — | 23,429 Common Stock | (F1) The convertible promissory note (the "Note") was issued to the Paul DiPerna Trust on April 30, 2021, in the principal aggregate amount of $102,663, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $9,788 and an outstanding balance of $112,451. Pursuant to its terms, the Note was automatically converted, on February 14, 2022, into (i) 23,429 shares of common stock of the Issuer and (ii) warrants to purchase 23,429 shares of common stock of the Issuer. |